NCT03257930 is a Phase 1 clinical trial of ethanol injection in Thyroid Nodule, sponsored by hassan harby mohamed.

Who is sponsoring NCT03257930?

NCT03257930 is sponsored by hassan harby mohamed.

What drugs are being tested in NCT03257930?

Interventions in NCT03257930: ethanol injection.

What condition does NCT03257930 study?

NCT03257930 studies Thyroid Nodule.

Is NCT03257930 still recruiting?

NCT03257930 is currently completed. Last updated 15 May 2020.

Last reviewed 2020-05-15 · How we verify

NCT03257930

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Percutaneous Ethanol Injection for Benign Cystic Thyroid Nodules

Completed Phase 1 Last updated 15 May 2020

What this trial tests

Phase 1 trial testing ethanol injection in Thyroid Nodule in 1 participant. Completed in 1 January 2019.

Timeline

11 August 2017

Primary endpoint
11 July 2018

1 January 2019

Quick facts

Lead sponsor	hassan harby mohamed
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	1
Start date	11 August 2017
Primary completion	11 July 2018
Estimated completion	1 January 2019
Sites	1 location across Egypt

Drugs / interventions tested

ethanol injection

Conditions studied

Thyroid Nodule — all drugs for Thyroid Nodule →

Sponsor

hassan harby mohamed

Who can join

Adults 15 to 60, any sex, with Thyroid Nodule. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Use of ethanol injection in treatment of cystic thyroid nodule

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Thyroid Nodule

Currently open trials in the same condition.

NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
NCT07488325 — Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytol · recruiting
NCT07370675 — Active Surveillance for Bethesda IV Thyroid Nodules · NA · recruiting
NCT07287176 — Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System · NA · recruiting
NCT06730321 — Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment · recruiting

Other hassan harby mohamed trials

Trials by the same sponsor.

NCT05296811 — Lateral Arm Free Flap for Reconstruction of the Oral Cavity and Head and Neck Soft Tissue Defects. · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03257930 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by hassan harby mohamed
Last refreshed: 15 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03257930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing